• IASbaba
  • May 6, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email


Part of: GS Prelims and GS – III – Sci & tech; Biotechnology 

In news

  • The CSIR- Centre for Cellular and Molecular Biology has developed, possibly the first specific drug for COVID-19 treatment, which contain therapeutic antibodies.

Key takeaways 

  • The Drug Controller General of India (DGCI) has given its approval for human trials, Phase-I and Phase-II for the VINCOV-19 and expected to be tried in Delhi and Rajasthan soon.
  • The VINCOV-19 is a collection of antibodies from Horses after they got injected with inactivated Corona virus.
  • The approval for its emergency use is expected once the results of phase I and II are declared.
  • It works best when given during early stage of infection.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....